Search

Your search keyword '"Heatstroke -- Drug therapy"' showing total 35 results
Start Over Descriptor "Heatstroke -- Drug therapy"
35 results on '"Heatstroke -- Drug therapy"'

3. Provn Of Septic Tank And Sokage Well To Bldg No P-164 At Udaipur Mil Stn And Provn Of 1x2 Ton Split Ac For Heat Stroke Treatment Room|cool Room At Sec Hosp And Provn Of Deficient Deep Freezer And Storage Water Heater For Or Cook Houses At Mil Stn Mou

Subjects
Heatstroke -- Drug therapy, Heating -- Equipment and supplies, Business, international
Abstract

Tenders are invited for Provn of septic tank and sokage well to bldg no p-164 at udaipur mil stn and provn of 1x2 ton split ac for heat stroke treatment [...]

Published
2023

5. Eagle Pharmaceuticals Announces Enrollment of Additional Exertional Heat Stroke Patients at the 2019 Hajj Pilgrimage

Subjects
United States. Food and Drug Administration, Eagle Pharmaceuticals Inc., Heatstroke -- Drug therapy, Dantrolene, Drug approval, Pilgrimages, Business, Business, international, Ryanodex (Medication)
Abstract

WOODCLIFF LAKE, N.J. -- Eagle Pharmaceuticals, Inc. ('Eagle' or the 'Company') (Nasdaq: EGRX) today provided an update on the Company's program for RYANODEX([R]) (dantrolene sodium for injectable suspension) for the [...]

Published
2019

6. Heat Stroke - symptoms and treatment

Subjects
Heatstroke -- Drug therapy, Heart rate, Brain damage, Nausea, Skin, Weather, Headache, General interest, News, opinion and commentary
Abstract

KARACHI: Dr Mubina Agboatwalla has issued the following news release: Children are very prone to develop heat stroke during this hot weather. This occurs when the outside temperature is very [...]

Published
2019

8. Eagle Pharmaceuticals Concludes Enrollment of Second Safety and Efficacy Study at Hajj to Evaluate RYANODEX for Exertional Heat Stroke

Subjects
Eagle Pharmaceuticals Inc., Clinical trials, Heatstroke -- Drug therapy, Medical research, General interest, News, opinion and commentary, Ryanodex (Medication)
Abstract

WOODCLIFF LAKE, N.J: Eagle Pharmaceuticals, Inc. has issued the following press release: Eagle Pharmaceuticals, Inc. ('Eagle' or 'the Company') (Nasdaq:EGRX) today announced completion of enrollment of the Company's second clinical [...]

Published
2018

9. Eagle Pharmaceuticals Concludes Enrollment of Second Safety and Efficacy Study at Hajj to Evaluate RYANODEX for Exertional Heat Stroke

Subjects
United States. Food and Drug Administration -- Planning, Eagle Pharmaceuticals Inc. -- Planning, Clinical trials, Heatstroke -- Drug therapy, Dantrolene -- Planning, Company business planning, Business, Business, international, Ryanodex (Medication)
Abstract

--Preliminary Analysis: RYANODEX Provides Benefit for Patients-- --Eagle Plans to Meet with FDA to Discuss Next Steps-- WOODCLIFF LAKE, N.J. -- Eagle Pharmaceuticals, Inc. ('Eagle' or 'the Company') (Nasdaq:EGRX) today [...]

Published
2018

11. FDA Grants Priority Review for Eagle Pharmaceuticals' Ryanodex NDA for the Treatment of Exertional Heat Stroke

Subjects
United States. Food and Drug Administration, Eagle Pharmaceuticals Inc., Heatstroke -- Drug therapy, Prescriptions (Drugs) -- Evaluation, General interest, News, opinion and commentary, Ryanodex (Medication) -- Evaluation
Abstract

Woodcliff Lake: Eagle Pharmaceuticals, Inc. has issued the following press release: Eagle Pharmaceuticals (Nasdaq:EGRX) ('Eagle' or 'the Company') announced today that their 505(b)(2) New Drug Application (NDA) for Ryanodex(r) (dantrolene [...]

Published
2017

12. FDA Grants Priority Review for Eagle Pharmaceuticals' Ryanodex NDA for the Treatment of Exertional Heat Stroke

Subjects
United States. Food and Drug Administration, Eagle Pharmaceuticals Inc., Heatstroke -- Drug therapy, Prescriptions (Drugs) -- Evaluation, General interest, News, opinion and commentary, Ryanodex (Medication) -- Evaluation
Abstract

Woodcliff Lake: Eagle Pharmaceuticals, Inc. has issued the following press release: -Eagle Pharmaceuticals (Nasdaq:EGRX) ('Eagle' or 'the Company') announced today that their 505(b)(2) New Drug Application (NDA) for Ryanodex(r) (dantrolene [...]

Published
2017

13. FDA Grants Priority Review for Eagle Pharmaceuticals' Ryanodex NDA for the Treatment of Exertional Heat Stroke

Subjects
United States. Food and Drug Administration, Eagle Pharmaceuticals Inc., Heatstroke -- Drug therapy, Prescriptions (Drugs) -- Evaluation, General interest, News, opinion and commentary, Ryanodex (Medication) -- Evaluation
Abstract

Woodcliff Lake: Eagle Pharmaceuticals, Inc. has issued the following press release: Eagle Pharmaceuticals (Nasdaq:EGRX) ('Eagle' or 'the Company') announced today that their 505(b)(2) New Drug Application (NDA) for Ryanodex(r) (dantrolene [...]

Published
2017

14. FDA Grants Priority Review for Eagle Pharmaceuticals' Ryanodex NDA for the Treatment of Exertional Heat Stroke

Subjects
United States. Food and Drug Administration, Eagle Pharmaceuticals Inc., Heatstroke -- Drug therapy, Dantrolene -- Evaluation, Prescriptions (Drugs) -- Evaluation, Business, Business, international, Ryanodex (Medication) -- Evaluation
Abstract

-PDUFA Date of July 23, 2017- WOODCLIFF LAKE, N.J. -- Eagle Pharmaceuticals (Nasdaq:EGRX) ('Eagle' or 'the Company') announced today that their 505(b)(2) New Drug Application (NDA) for Ryanodex[R] (dantrolene sodium) [...]

Published
2017

16. Eagle Pharmaceuticals Completes NDA Submission for Ryanodex for Exertional Heat Stroke to FDA

Subjects
United States. Food and Drug Administration, Eagle Pharmaceuticals Inc., Heatstroke -- Drug therapy, Drug approval, Prescriptions (Drugs), General interest, News, opinion and commentary, Ryanodex (Medication)
Abstract

Woodcliff Lake: Eagle Pharmaceuticals, Inc. has issued the following press release: Eagle Pharmaceuticals, Inc. (Nasdaq:EGRX) ('Eagle' or 'the Company') today announced that it has completed the submission of its 505(b)(2) [...]

Published
2017

17. Eagle Pharmaceuticals Completes NDA Submission for Ryanodex for Exertional Heat Stroke to FDA

Subjects
United States. Food and Drug Administration, Eagle Pharmaceuticals Inc., Heatstroke -- Drug therapy, Drug approval, Prescriptions (Drugs), General interest, News, opinion and commentary, Ryanodex (Medication)
Abstract

Woodcliff Lake: Eagle Pharmaceuticals, Inc. has issued the following press release: Eagle Pharmaceuticals, Inc. (Nasdaq:EGRX) ('Eagle' or 'the Company') today announced that it has completed the submission of its 505(b)(2) [...]

Published
2017

18. Eagle Pharmaceuticals Completes NDA Submission for Ryanodex for Exertional Heat Stroke to FDA

Subjects
United States. Food and Drug Administration, Eagle Pharmaceuticals Inc., Heatstroke -- Drug therapy, Drug approval, Prescriptions (Drugs), General interest, News, opinion and commentary, Ryanodex (Medication)
Abstract

Woodcliff Lake: Eagle Pharmaceuticals, Inc. has issued the following press release: Eagle Pharmaceuticals, Inc. (Nasdaq:EGRX) ('Eagle' or 'the Company') today announced that it has completed the submission of its 505(b)(2) [...]

Published
2017

19. Eagle Pharmaceuticals Completes NDA Submission for Ryanodex for Exertional Heat Stroke to FDA

Subjects
United States. Food and Drug Administration, Eagle Pharmaceuticals Inc., Heatstroke -- Drug therapy, Drug approval, Business, Business, international, Ryanodex (Medication)
Abstract

-Ryanodex could offer a new standard of care for this serious and life-threatening condition- WOODCLIFF LAKE, N.J. -- Eagle Pharmaceuticals, Inc. (Nasdaq:EGRX) ('Eagle' or 'the Company') today announced that it [...]

Published
2017

20. Eagle Pharmaceuticals Concludes Enrollment of Second Safety and Efficacy Study at Hajj to Evaluate Ryanodex for Exertional Heat Stroke

Subjects
Eagle Pharmaceuticals Inc., Clinical trials, Heatstroke -- Drug therapy, Dantrolene, Chemistry, Ryanodex (Medication)
Abstract

M2 PHARMA-August 31, 2018-Eagle Pharmaceuticals Concludes Enrollment of Second Safety and Efficacy Study at Hajj to Evaluate Ryanodex for Exertional Heat Stroke (C)2018 M2 COMMUNICATIONS - US-based specialty pharmaceutical company [...]

Published
2018

21. Eagle Pharmaceuticals Reports Positive Results from Pivotal Animal Study Supporting the Efficacy of RYANODEX for Exertional Heat Stroke

Subjects
Eagle Pharmaceuticals Inc., Heatstroke -- Drug therapy, General interest, News, opinion and commentary, Ryanodex (Medication)
Abstract

Woodcliff Lake: Eagle Pharmaceuticals, Inc. has issued the following press release: Eagle Pharmaceuticals ('Eagle' or the 'Company') (NASDAQ:EGRX) today announced positive results from its pivotal animal study conducted under the [...]

Published
2016

22. Eagle Pharmaceuticals Reports Positive Results from Pivotal Animal Study Supporting the Efficacy of RYANODEX for Exertional Heat Stroke

Subjects
Eagle Pharmaceuticals Inc., Heatstroke -- Drug therapy, General interest, News, opinion and commentary, Ryanodex (Medication)
Abstract

Woodcliff Lake: Eagle Pharmaceuticals, Inc. has issued the following press release: -Eagle Pharmaceuticals ('Eagle' or the 'Company') (NASDAQ:EGRX) today announced positive results from its pivotal animal study conducted under the [...]

Published
2016

23. Eagle Pharmaceuticals Reports Positive Results from Pivotal Animal Study Supporting the Efficacy of RYANODEX for Exertional Heat Stroke

Subjects
Eagle Pharmaceuticals Inc., Heatstroke -- Drug therapy, General interest, News, opinion and commentary, Ryanodex (Medication)
Abstract

Woodcliff Lake: Eagle Pharmaceuticals, Inc. has issued the following press release: -Eagle Pharmaceuticals ('Eagle' or the 'Company') (NASDAQ:EGRX) today announced positive results from its pivotal animal study conducted under the [...]

Published
2016

24. Eagle Pharmaceuticals Reports Positive Results from Pivotal Animal Study Supporting the Efficacy of RYANODEX for Exertional Heat Stroke

Subjects
United States. Food and Drug Administration, Eagle Pharmaceuticals Inc., Heatstroke -- Drug therapy, Business, Business, international, Ryanodex (Medication)
Abstract

-- Animal study conducted under the Animal Rule met primary efficacy endpoint -- --Ryanodex-treated animals showed a greater proportion of subjects achieving reversal of heat stroke/hypermetabolic crisis -- -- Animal [...]

Published
2016

26. Eagle Pharmaceuticals Initiates Rolling Submission of NDA for Ryanodex in Exertional Heat Stroke

Subjects
United States. Food and Drug Administration, Eagle Pharmaceuticals Inc., Heatstroke -- Drug therapy, Dantrolene, Business, Business, international, Ryanodex (Medication)
Abstract

WOODCLIFF LAKE, N.J. -- Eagle Pharmaceuticals ('Eagle' or the 'Company') (NASDAQ: EGRX) today announced that the Company has initiated the rolling submission of its New Drug Application (NDA) and filed [...]

Published
2016

27. Researchers Validate Revolutionary Heat Stroke Treatment

Subjects
Labs Inc., Heatstroke -- Drug therapy, Cooling systems, Business, general
Abstract

Kingsport, TN (PRWEB) February 07, 2016 Per Vivo Labs, Inc., is excited to announce that this week a team of scientific researchers, led by Dr. Brent Ruby, Ph.D., FACSM, released [...]

Published
2016

28. FDA Grants Fast Track Designation to RYANODEX for Treatment of Exertional Heat Stroke; Fast Track Designation Highlights Serious, Unmet Medical Need that Exists for Patients with EHS

Subjects
United States. Food and Drug Administration, Eagle Pharmaceuticals Inc., Heatstroke -- Drug therapy, Dantrolene, Drug approval, Business, Business, international, Ryanodex (Medication)
Abstract

WOODCLIFF LAKE, N.J. -- Eagle Pharmaceuticals ('Eagle' or the 'Company') (NASDAQ:EGRX) today announced that the U.S. Food and Drug Administration ('FDA') has granted Fast Track designation to its RYANODEX[R] (dantrolene [...]

Published
2016

29. FDA Grants Priority Review for Eagle Pharmaceuticals' Ryanodex NDA for the Treatment of Exertional Heat Stroke

Subjects
United States. Food and Drug Administration, Heatstroke -- Drug therapy, Eagles, Dantrolene -- Evaluation, Prescriptions (Drugs) -- Evaluation, Business, Pharmaceuticals and cosmetics industries, Health, Ryanodex (Medication) -- Evaluation
Abstract

2017 APR 10 (NewsRx) -- By a News Reporter-Staff News Editor at Pharma Business Week -- Eagle Pharmaceuticals (Nasdaq:EGRX) ('Eagle' or 'the Company') announced that their 505(b)(2) New Drug Application [...]

Published
2017

30. FDA Grants Priority Review for Eagle Pharmaceuticals' NDA for Ryanodex as Exertional Heat Stroke Treatment

Subjects
United States. Food and Drug Administration, Heatstroke -- Drug therapy, Dantrolene, Prescriptions (Drugs), Chemistry, Ryanodex (Medication)
Abstract

M2 PHARMA-March 27, 2017-FDA Grants Priority Review for Eagle Pharmaceuticals' NDA for Ryanodex as Exertional Heat Stroke Treatment (C)2017 M2 COMMUNICATIONS - US-based specialty pharmaceutical company Eagle Pharmaceuticals' (NASDAQ: EGRX) [...]

Published
2017

31. Eagle Pharmaceuticals Completes NDA Submission for Ryanodex for Exertional Heat Stroke to FDA

Subjects
United States. Food and Drug Administration, Eagle Pharmaceuticals Inc., Heatstroke -- Drug therapy, Eagles, Drug approval, Prescriptions (Drugs), Business, Pharmaceuticals and cosmetics industries, Health, Ryanodex (Medication)
Abstract

2017 FEB 6 (NewsRx) -- By a News Reporter-Staff News Editor at Pharma Business Week -- Eagle Pharmaceuticals, Inc. (Nasdaq:EGRX) ('Eagle' or 'the Company') announced that it has completed the [...]

Published
2017

32. FDA Grants Fast Track Designation to RYANODEX for Treatment of Exertional Heat Stroke; Fast Track Designation Highlights Serious, Unmet Medical Need that Exists for Patients with EHS

Subjects
United States. Food and Drug Administration, Heatstroke -- Drug therapy, Business, Government, Political science, Ryanodex (Medication)
Abstract

2016 FEB 18 (VerticalNews) -- By a News Reporter-Staff News Editor at Politics & Government Business -- Eagle Pharmaceuticals ('Eagle' or the 'Company') (NASDAQ:EGRX) announced that the U.S. Food and [...]

Published
2016

33. Eagle Pharma gets US FDA Fast Track status to Ryanodex for exertional heat stroke treatment

Subjects
United States. Food and Drug Administration, Heatstroke -- Drug therapy, Dantrolene, Drug approval, Business, Business, international, Ryanodex (Medication)
Abstract

Eagle Pharmaceuticals announced that the US Food and Drug Administration (FDA) has granted Fast Track designation to its Ryanodex (dantrolene sodium for injectable suspension) for the treatment of exertional heat [...]

Published
2016

Catalog

Books, media, physical & digital resources
See catalog results